Tackling Multifactorial Alzheimer’s Disease

Virtual Only

ACS Fall 2025
Global Virtual Symposium

Ìý

Progress in Understanding and Tackling Multifactorial Alzheimer's Disease

Medicinal Chemistry

Alzheimer’s disease (AD) is a complex neurodegenerative disorder and a primary cause of dementia. Despite extensive research, effective diagnostic and therapeutic options for AD remain elusive. Nevertheless, recent advancements in understanding the disease mechanisms hold promise for developing potential diagnostic and therapeutic solutions. This Global Virtual Symposia aims to discuss these recent developments comprehensively, enhancing our understanding of the multifactorial nature of Alzheimer’s disease, and facilitating the creation of effective diagnostics and therapeutics.

Symposium Features

Present your research in your local time zone

Inviting all early career chemists from across the globe to deliver flash presentations.

Get exposure and recognition

As a presenter, you will receive a certificate of participation at ACS Meetings.

Abstracts will be listed in the CAS database and can be added to your Google Scholar profile.

Symposium schedule

The symposium will feature multiple sessions from August 17-21.

Sessions will be programmed at convenient daytimes of multiple regions such as Asia, the Middle East, Africa, Latin America, and Oceania; however, for the Americas, these sessions will be at early mornings and evenings.

Symposium Chairs

T. Govindaraju

T. Govindaraju
Jawaharlal Nehru Centre for Advanced Scientific Research, IndiaÌý

Christelle Hureau

Christelle Hureau
Alzheimer's, Amyloids and Bio-inorganic Chemistry, Coordination Chemistry Lab in Toulouse, FranceÌý

Shai Rahimipour

Shai Rahimipour
Bar-Ilan University, Israel

Plenary Speakers

Andrew D. Hamilton
New York University, United States

Pamela Maher
Salk Institute for Biological Studies, United States

Ayyalusamy Ramamoorthy
FAMU-FSU College of Engineering, United States

Invited Speakers

Aphrodite Kapurniotu
Technische Universität München, Germany

Benedict C. Albensi
Nova Southeastern University, United States

Tessa Sinnige
Utrecht University, The Netherlands

Peter Faller
University of Strasbourg, France

Tim Storr
Simon Fraser University, Canada

Cláudio M. Gomes
University of Lisbon, Portugal

Jinghui Luo
Paul Scherrer Institute, Switzerland

Douglas Johnson
Biogen, United States

Subashchandrabose Chinnathambi
National Institute of Mental Health and Neuro Sciences, India

Liviu Mirica
University of Illinois Urbana-Champaign, United States

Sandra E. Encalada
The Scripps Research Institute, United States

Yifat Miller
Ben-Gurion University of the Negev, Israel

Sara Lins
Lund University, Sweden

Vijay Rangachari
University of Southern Mississippi, United States

Daniela Valensin
University of Siena, Italy

Yanlian Yang
National Center for Nanoscience and Technology, China

Frequently Asked Questions

  • What are Flash presentations?

    They are brief, impactful, and convey information about a novel protocol, perspective, technique, or research results. For instance, one Flash Talk may describe an innovative interdisciplinary research outcome. Another may describe results for a pilot/prototype study.

  • Can I submit an abstract if I'm not an early career researcher?

    This symposium focuses on early career researchers, but all researchers are welcome to attend. However, the format of the presentation will be 8 minutes flash talk.

  • What is the submission deadline for abstracts?

    The submission deadline for abstracts is March 31, 11:59 PM ET.

  • What is the required format for abstracts?

    Abstracts should be 2500 characters or less and include the title, author(s), and a concise description of your research.

  • Can I include images or figures in my abstract?

    Yes, limited use of images or figures is permitted to enhance your abstract's content.

  • When will I know if my abstract is accepted?

    Presenters can expect to receive their acceptance notices approximately 3 months before the meeting. Scheduling notices are sent periodically starting approximately 2 months before the meeting.

  • What if I can't attend the symposium on the scheduled date?

    The Global Virtual Symposia does not have provision for recorded talks. Presenters can only present in real-time. However, for any rescheduling requests, please reach out to our symposium chairs and organizers beforehand.

  • Do I need to register separately if my abstract is accepted?

    Yes, accepted presenters will have to register for ACS Fall 2025. Symposium organizers will reach out to confirm their participation.